Igor Bilinsky insider trades

Open-market stock purchases and sales by Igor Bilinsky, Chief Operating Officer at Iovance Biotherapeutics, Inc, from SEC Form 4 filings since Jan 7, 2014.

Recent trades

DateStockTradeValue
Jun 5, 2026IOVA Iovance Biotherapeutics, IncSold (not open market)$16.8K
Jun 5, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Jun 1, 2026IOVA Iovance Biotherapeutics, IncSold (not open market)$17.7K
Jun 1, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Mar 9, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Mar 5, 2026IOVA Iovance Biotherapeutics, IncSold (not open market)$76.2K
Mar 5, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Mar 2, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Mar 2, 2026IOVA Iovance Biotherapeutics, IncSold (not open market)$26.2K
Mar 2, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Mar 2, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Dec 2, 2025IOVA Iovance Biotherapeutics, IncSold (not open market)$3.8K
Dec 2, 2025IOVA Iovance Biotherapeutics, IncBought (not open market)—
Dec 1, 2025IOVA Iovance Biotherapeutics, IncSold (not open market)$10K
Dec 1, 2025IOVA Iovance Biotherapeutics, IncBought (not open market)—

Companies traded

  • IOVA Iovance Biotherapeutics, Inc: other filings, last Jun 5, 2026
  • ONCT Oncternal Therapeutics, Inc: other filings, last Feb 11, 2021
  • APHB AmpliPhi Biosciences Corp: other filings, last May 30, 2017
  • RXDX Ignyta, Inc: other filings, last Jan 7, 2016
  • VICL Vical Inc: 1 buy, 7 sales, last Jul 13, 2015

Get free alerts when Igor Bilinsky files a new trade →